We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00241267
First Posted: October 18, 2005
Last Update Posted: October 6, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Tours
October 14, 2005
October 18, 2005
October 6, 2006
March 2005
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00241267 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease
Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease

The exploration of neoplastic pulmonary pathology is based on computed tomography and bronchoscopy. This allows targeted samples of the identified lesions.

A new ultrasonographic method is proposed as a non invasive and non irradiating technic by using a dedicated probe easily introduced via the channel of the fibrescope, so as to complete the identification of peripheral lesions.

The main objective of the study is to assess the ability of endobronchial ultrasonography to diagnose peripheral pulmonary lesions during the bronchoscopy and to correlate the abnormalities to computed tomography and/or histology.

The dedicated probe consist of a linear array of 2-3 mm in diameter connected to a commercial unit.

Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Pulmonary Neoplasms
Device: Dedicated ultrasonographic probe during bronchoscopy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
20
March 2006
Not Provided

Inclusion Criteria:

  • Assumed proximal neoplastic pulmonary pathology
  • Planned bronchoscopy and biopsy

Exclusion Criteria:

  • Pregnancy
  • Breastfeeding
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT00241267
CT04-FT/ENDO
Not Provided
Not Provided
Not Provided
Not Provided
University Hospital, Tours
Not Provided
Principal Investigator: François TRANQUART, PR Centre d'Innovation Technologique
University Hospital, Tours
May 2006